J. Tanianis-Hughes

发表

Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer

C. Streuli, R. Clarke, Fiona M. Foster, 2009, Breast Cancer Research.

Predicting P-Glycoprotein Effects on Oral Absorption: Correlation of Transport in Caco-2 with Drug Pharmacokinetics in Wild-Type and mdr1a(-/-) Mice in Vivo

D. Hallifax, A. Collett, G. Warhurst, 2004, Pharmaceutical Research.

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021 .

Comparison of P-glycoprotein-mediated drug-digoxin interactions in Caco-2 with human and rodent intestine: relevance to in vivo prediction.

A. Collett, G. Warhurst, J. Tanianis-Hughes, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2022, The Lancet Digital Health.

Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process.

G. Warhurst, J. Tanianis-Hughes, G. Carlson, 2005, Gastroenterology.

Region-Dependent Modulation of Intestinal Permeability by Drug Efflux Transporters: In Vitro Studies in mdr1a(−/−) Mouse Intestine

G. Warhurst, J. Tanianis-Hughes, M. Humphrey, 2002, Journal of Pharmacology and Experimental Therapeutics.

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet Respiratory Medicine.

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Jordan J. Clark, Michael J. Murphy, Quentin J. Leclerc, 2021, BMC Health Services Research.

Bax Exists in a Dynamic Equilibrium between the Cytosol and Mitochondria to Control Apoptotic Priming

C. Streuli, Pengbo Wang, A. Gilmore, 2013, Molecular cell.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Analysis of inhibitor of apoptosis protein family expression during mammary gland development

C. Streuli, Fiona M. Foster, T. Owens, 2010, BMC Developmental Biology.

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet. Microbe.

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Panteleimon G. Takis, Jordan J. Clark, Michael J. Murphy, 2021, The Lancet.

Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?

A. Collett, G. Warhurst, J. Tanianis-Hughes, 2004, Biochemical pharmacology.

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet Rheumatology.

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet. Respiratory medicine.

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2023, Genome Biology.

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2020, American journal of respiratory and critical care medicine.

Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2020, BMJ.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Panteleimon G. Takis, Jordan J. Clark, Michael J. Murphy, 2022, eBioMedicine.

Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

Panteleimon G. Takis, Megan L. Nagel, S. Sawcer, 2023, Nature communications.